Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nuhn

Showing results (281-290 of 306) with videos related to

Pageof 31
Sort By:
Journal of the American Chemical Society|June 24, 2021
Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7/8 Agonistic Immune ModulatorsAnne Huppertsberg, Leonard Kaps, Zifu Zhong, et al.
Urologic Oncology|November 8, 2011
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4aMatthias May, Patrick J Bastian, Sabine Brookman-May, et al.
Minerva Urology and Nephrology|November 28, 2024
Robot-assisted partial nephrectomy of multiple tumors: a multicenter analysisPouriya Faraj Tabrizi, Philip Zeuschner, Olga Katzendorn, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2022
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinomaNiklas Klümper, Danijel Sikic, Jonas Saal, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 31, 2012
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladderP Nuhn, M May, H-M Fritsche, et al.
Urologic Oncology|June 11, 2016
Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladderStefan Vallo, Christian Gilfrich, Maximilian Burger, et al.
European Urology|January 7, 2014
Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohortAtiqullah Aziz, Matthias May, Maximilian Burger, et al.
Clinical Genitourinary Cancer|October 22, 2016
The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among CliniciansThomas Martini, Christian Gilfrich, Roman Mayr, et al.
World Journal of Urology|June 6, 2013
Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validationM Gierth, H M Fritsche, H Buchner, et al.
The Review of Scientific Instruments|September 3, 2016
Circular dichroism measurements at an x-ray free-electron laser with polarization controlG Hartmann, A O Lindahl, A Knie, et al.
Pageof 31

Showing results (281-290 of 306) with videos related to

Sort By:
Pageof 31
Journal of the American Chemical Society|June 24, 2021
Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7/8 Agonistic Immune ModulatorsAnne Huppertsberg, Leonard Kaps, Zifu Zhong, et al.
Urologic Oncology|November 8, 2011
Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4aMatthias May, Patrick J Bastian, Sabine Brookman-May, et al.
Minerva Urology and Nephrology|November 28, 2024
Robot-assisted partial nephrectomy of multiple tumors: a multicenter analysisPouriya Faraj Tabrizi, Philip Zeuschner, Olga Katzendorn, et al.
European Journal of Cancer (Oxford, England : 1990)|April 2, 2022
C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinomaNiklas Klümper, Danijel Sikic, Jonas Saal, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 31, 2012
External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladderP Nuhn, M May, H-M Fritsche, et al.
Urologic Oncology|June 11, 2016
Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladderStefan Vallo, Christian Gilfrich, Maximilian Burger, et al.
European Urology|January 7, 2014
Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohortAtiqullah Aziz, Matthias May, Maximilian Burger, et al.
Clinical Genitourinary Cancer|October 22, 2016
The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among CliniciansThomas Martini, Christian Gilfrich, Roman Mayr, et al.
World Journal of Urology|June 6, 2013
Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validationM Gierth, H M Fritsche, H Buchner, et al.
The Review of Scientific Instruments|September 3, 2016
Circular dichroism measurements at an x-ray free-electron laser with polarization controlG Hartmann, A O Lindahl, A Knie, et al.
Pageof 31